Form 8-K - Current report:
SEC Accession No. 0000912282-14-000215
Filing Date
2014-04-23
Accepted
2014-04-23 13:29:07
Documents
4
Period of Report
2014-04-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antriabio8k_04232014.htm 8-K 26183
2 ex99_1.htm EX-99.1 2215
3 pr_1.jpg GRAPHIC 390524
4 pr_2.jpg GRAPHIC 342028
  Complete submission text file 0000912282-14-000215.txt   1039076
Mailing Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025
Business Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 14778297
SIC: 2834 Pharmaceutical Preparations